Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats

dc.contributor.authorLópez Arnau, Raúl
dc.contributor.authorBuenrostro Jáuregui, Mario
dc.contributor.authorCamarasa García, Jordi
dc.contributor.authorPubill Sánchez, David
dc.contributor.authorEscubedo Rafa, Elena
dc.date.accessioned2020-07-03T09:07:55Z
dc.date.available2020-07-03T09:07:55Z
dc.date.issued2018-01-18
dc.date.updated2020-07-03T09:07:55Z
dc.description.abstractCathinones, such as mephedrone (Meph), are often co-abused with alcoholic drinks. In the present study, we investigated the combined effects of Meph plus ethanol (EtOH) on neurotransmitter release in the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC). A guide canula was stereotaxically implanted into either the NAc or the mPFC of male Sprague-Dawley rats. Seven days after surgery, a microdialysis probe was inserted and rats were administered saline, EtOH (1 g/kg, i.p.), Meph (25 mg/kg, s.c.), or their combination, and dialysates were collected. Serotonin (5-HT), dopamine (DA), and their metabolites (5-HIAA, DOPAC and HVA) were determined through high-pressure liquid chromatography coupled to mass spectrometry. 5-HT and DA peaked 40 min after Meph administration (with or without EtOH co-treatment) in both areas. EtOH combined with Meph increased the 5-HT release compared with the rats receiving Meph alone (85% in NAc, 65% in mPFC), although the overall change in the area under the curve only reached statistical significance in the NAc. In mPFC, the increased release of 5-HT lasted longer in the combination than that in the Meph group. Moreover, EtOH potentiated the psychostimulant effect of Meph measured as a locomotor activity. Given that both 5-HT and DA are also related with reward and impulsivity, the observed effects point to an increased risk of abuse liability when combining Meph with EtOH compared with consuming these drugs alone.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec675606
dc.identifier.issn0028-1298
dc.identifier.urihttps://hdl.handle.net/2445/167442
dc.language.isoeng
dc.publisherSpringer Verlag
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1007/s00210-018-1464-x
dc.relation.ispartofNaunyn-Schmiedebergs Archives of Pharmacology, 2018, vol. 391, num. 3, p. 247-254
dc.relation.urihttps://doi.org/10.1007/s00210-018-1464-x
dc.rights(c) Springer Verlag, 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationFarmacologia
dc.subject.classificationFarmacocinètica
dc.subject.classificationAmfetamines
dc.subject.classificationDrogoaddicció
dc.subject.classificationRates (Animals de laboratori)
dc.subject.otherPharmacology
dc.subject.otherPharmacokinetics
dc.subject.otherAmphetamines
dc.subject.otherDrug addiction
dc.subject.otherRats as laboratory animals
dc.titleEffect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
675606.pdf
Mida:
550.73 KB
Format:
Adobe Portable Document Format